Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple MyelomaAshraf Badros, Steven Grant, Olga Goloubeva et al.|Clinical Cancer Research|2009Cited by 230
Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: A single center studyVishal Bhatnagar, Ashraf Badros, Yin Wu et al.|Cancer|2014Cited by 55
Phase I Trial of Suberoylanilide Hydroxamic Acid (SAHA) + Bortezomib (Bort) in Relapsed Multiple Myeloma (MM) Patients (pts).Ashraf Badros, Merrill J. Egorin, S. Philip et al.|Blood|2007Cited by 25